In contrast with the previous results seen with lung or colon cancers (in which all three modalities gave similar results), RLIP76 antisense was significantly more effective in killing pancreatic cancer cells than the RLIP76 antibody (Fig. 1B). This evidence concerns the gene RALBP1 and familial pancreatic carcinoma.